Garry A. Nicholson - 12 Sep 2022 Form 3 Insider Report for Day One Biopharmaceuticals, Inc. (DAWN)

Role
Director
Signature
/s/ By Charles N. York II, as Attorney-in-Fact for Reporting Person
Issuer symbol
DAWN
Transactions as of
12 Sep 2022
Net transactions value
$0
Form type
3
Filing time
14 Sep 2022, 19:32:24 UTC
Previous filing
17 Aug 2022
Next filing
16 Jun 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding DAWN No securities beneficially owned. 0 12 Sep 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

Exhibit 24.1 Power of Attorney